Trichomoniasis, chlamydia, and gonorrhea are the three most prevalent, treatable STDs in the U.S. If left untreated, complications can include infertility, pelvic inflammatory disease, pregnancy complications, and increased risk of HIV acquisition.1
CDC recommends:
Annual CT/NG screening of all sexually active women under 25
Screening of other at-risk individuals including MSM*
Testing for chlamydia, gonorrhea, & trichomoniasis using NAATs^ (PCR)
Timely testing to support prompt treatment decisions
The Solution
Accurate on-demand PCR results are ready when you need them
On‑demand results can support clinical workflows by providing results during the patient visit
The test supports the use of patient‑collected vaginal swab specimens in clinical settings
The assay supports multiple validated specimen types
The Impact
Provide fast patient results to:
Enable test results during the patient visit
Support efficient patient care workflows
Support timely identification of infection to inform clinical management.
Help inform appropriate clinical decision‑making regarding antibiotic use